Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:33 PM ET 10-Q
Financial Results Alto Neuroscience, Inc. ANRO

Alto Neuroscience Q3 2026 Results: Net Loss of $25.1M, Loss Widens

Alto Neuroscience reported a net loss of $79.0 million for the nine months ended September 30, 2026, compared to $47.1 million in the prior year, driven by a significant increase in research and development expenses. The company strengthened its balance sheet through a private placement and direct shelf offering, ending the period with $319.3 million in cash and cash equivalents.

Key figure
Net loss $25.1M
4:33 PM ET 10-Q
Financial Results West Coast Community Bancorp WCCB

West Coast Community Bancorp Q3 2026 Results: Net Income $16.7M, Up 38.8% YoY

West Coast Community Bancorp reported net income of $43.9 million for the nine months ended September 30, 2026, an increase from $36.7 million in the prior year period. Total assets grew to $2.98 billion, driven by a $164.5 million increase in loans held for investment, while the company successfully retired its subordinated debentures during the period.

Key figure
Net income $16.7M · +38.8% YoY
4:32 PM ET 10-Q
Financial Results Zion Oil & Gas Inc ZNOG

Zion Oil & Gas Q3 2026 Results: Net Loss of $1.78M, Loss Widens

Zion Oil & Gas reported a net loss of $5.9 million for the nine months ended September 30, 2026, compared to $5.3 million in the prior year period. The company remains in the exploration phase with $38.4 million invested in unproved oil and gas properties and continues to fund operations primarily through the sale of common stock and exercise of warrants, raising $17.3 million during the first nine months of 2026.

Key figure
Net loss $1.78M
4:32 PM ET 10-Q
Financial Results Waters Corp WAT

Waters Q3 2026 Results: Net Income $81M, Down 45.6% YoY

Waters Corp reported a significant increase in total net revenues to $1.77 billion for the third quarter of 2026, driven by the BDS Business Acquisition. However, the company recorded a net loss of $127 million for the first nine months of 2026, primarily due to higher interest expenses and substantial amortization of purchased intangibles following the acquisition.

Key figure
Net income $81M · -45.6% YoY
4:32 PM ET 10-Q
Financial Results Lake Shore Bancorp, Inc. LSBK

Lake Shore Bancorp Q3 2026 Results: Net Income $2.31M, Down 1.9% YoY

Lake Shore Bancorp reported net income of $6.4 million for the nine months ended September 30, 2026, an increase from $5.3 million in the prior year period, driven primarily by higher net interest income. Total assets grew slightly to $734.2 million, while the company experienced a significant unrealized loss on securities available for sale, impacting accumulated other comprehensive loss.

Key figure
Net income $2.31M · -1.9% YoY
4:32 PM ET 10-Q
Financial Results Clearone Inc CLRO

Clearone Q3 2026 Results: Net Loss of $709K, Loss Narrows

ClearOne, Inc. reported zero revenue for the quarter ended September 30, 2026, following the sale of its operating assets in late 2025. The company recorded a net loss of $0.7 million for the quarter and is currently focused on fulfilling legacy obligations and pursuing a merger with Cortigent, Inc. and Vivani Medical, Inc. while facing potential Nasdaq delisting.

Key figure
Net loss $709K
4:32 PM ET 10-Q
Financial Results Datacentrex, Inc. DTCX

Datacentrex Q3 2026 Results: Net Loss of $2.61M, Loss Widens

Datacentrex, Inc. reported a net loss of $14.2 million for the nine months ended September 30, 2026, compared to a $3.4 million loss in the prior year period, driven by significantly higher depreciation and stock-based compensation. Despite the net loss, the company increased its total assets to $72.9 million, bolstered by a $30 million investment in ELNG Equity LLC and proceeds from a public offering.

Key figure
Net loss $2.61M
4:32 PM ET 10-Q
Financial Results Kopin Corp KOPN

Kopin Q3 2026 Results: Net Loss of $3.42M

Kopin Corp reported total revenues of $18.2 million for the quarter ended September 26, 2026, a significant increase from $12.0 million in the prior year, driven by higher research and development revenues and grant income. Despite the revenue growth, the company realized a net loss of $3.4 million for the quarter, compared to a net income of $4.1 million in the same period in 2025.

Key figure
Net loss $3.42M
4:32 PM ET 10-Q
Financial Results Marathon Bancorp, Inc. MBBC

Marathon Bancorp Q1 2026 Results: Net Income $453K, Up 1.9% YoY

Marathon Bancorp reported net income of $452,896 for the quarter ended September 30, 2026, a slight increase from $444,293 in the prior year period. Total assets decreased slightly to $258.9 million, while total deposits grew by approximately $11.3 million during the quarter, offset by a $15 million reduction in FHLB advances.

Key figure
Net income $453K · +1.9% YoY
4:32 PM ET 8-K
Financial Results Urban One, Inc. UONE

Urban One Financial Results

Urban One reported a net revenue decrease of 5.0% to $88.0 million for Q3 2026, driven by adverse market conditions in radio and weak demand in the Cable TV scatter market. The company reported a significant net loss of $119.2 million, primarily due to a $128.9 million impairment charge on goodwill and intangible assets. Management lowered its full-year 2026 Adjusted EBITDA guidance to $40.0 million and identified $20.0 million in annualized cost savings for the upcoming year.

Term
3 months

“Market conditions in radio continued to adversely impact revenue in the third quarter. We were helped by net political revenue of over $0.8 million in the quarter and the acquisition of stations in our Dallas market, effective July 17th, which contributed an additional $1.9 million of net revenue in the quarter.”

Alfred C. Liggins, III, Urban One’s CEO and President

“Revised Adjusted EBITDA guide for 2026 is now $40.0 million given the realities of the current advertising marketplace. Management is hyper-focused on cost reductions heading into next year and has identified at least $20.0 million of annualized savings.”

Alfred C. Liggins, III, Urban One’s CEO and President
4:32 PM ET 10-Q
Financial Results LENSAR, Inc. LNSR

LENSAR Q3 2026 Results: Net Loss of $4.72M, Loss Widens

LENSAR, Inc. is focused on the commercialization of its ALLY Robotic Cataract Laser System while navigating the aftermath of a terminated Merger Agreement. The company continues to report operating losses and emphasizes risks related to macroeconomic conditions, regulatory clearances, and patient willingness to pay for advanced cataract procedures.

Key figure
Net loss $4.72M
4:32 PM ET 10-Q
Financial Results Stran & Company, Inc. SWAG ▶ Call

Stran & Company Q3 2026 Results: Turns Profitable, Net Income $35K

Stran & Company, Inc. reported a net income of $1.09 million for the nine months ended September 30, 2026, compared to a net loss of $0.99 million in the prior year period. Total sales increased to $92.7 million from $87.3 million, while the company maintained a strong cash position of $7.38 million as of the end of the third quarter.

Key figure
Net income $35K
4:32 PM ET 10-Q
Financial Results Harvard Bioscience Inc HBIO

Harvard Bioscience Q3 2026 Results: Net Loss of $2.62M, Loss Widens

Harvard Bioscience reported revenues of $22.2 million for Q3 2026, a slight increase from $20.6 million in the prior year, though the company recorded a net loss of $2.6 million. For the nine months ended September 30, 2026, the net loss was $9.0 million compared to a $53.9 million loss in 2025, which had been driven by a significant $48.0 million goodwill impairment charge.

Key figure
Net loss $2.62M
4:32 PM ET 10-Q
Financial Results Biomea Fusion, Inc. BMEA

Biomea Fusion Q3 2026 Results: Net Loss of $6.18M, Loss Narrows

Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for diabetes and obesity. The filing indicates substantial doubt about the company's ability to continue as a going concern, highlighting a critical need for additional capital to fund ongoing research and development of its lead candidates, icovamenib and BMF-650.

Key figure
Net loss $6.18M
4:32 PM ET 10-Q
Financial Results Humacyte, Inc. HUMA

Humacyte Q3 2026 Results: Net Loss of $15.5M, Loss Narrows

Humacyte, Inc. reported a significant increase in cash and cash equivalents to $64.5 million as of September 30, 2026, following the commercialization of Symvess. The company recorded a litigation settlement liability of $9.75 million and an accumulated deficit of $796.8 million, while common stock outstanding grew to over 277 million shares.

Key figure
Net loss $15.5M
4:32 PM ET 8-K
Financial Results Meridian Holdings Inc. MRDN

Meridian Holdings Financial Results

Meridian Holdings reported Q3 2026 revenue of $46.0 million, a 3% year-over-year decrease, and a net loss of $13.3 million. The loss was primarily driven by $11.5 million in non-cash impairment charges, including a full write-off of its Brazilian gaming license following regulatory changes. Despite the quarterly loss, nine-month revenue rose 10% to $146.3 million and the company reduced total debt by 47% to $24.1 million.

Term
Q3 2026

“This was a challenging quarter, impacted by customer-favorable sports results, regulatory developments in Brazil and higher operating costs. Brazil suspended fixed-odds betting, including online casinos, by all operators. Our core business remains healthy and outside one-off adjustments continues to generate cash to drive its own growth.”

Zoran Milosevic, Chief Executive Officer of Meridian Holdings

“In the fourth quarter, historically our strongest, we expect higher betting volume and continued momentum in online casino. We remain focused on improving margins and driving operational efficiency through more targeted marketing and promotional costs, continued optimization of our retail footprint and expected growth in higher-margin online casino, with a goal of returning to the profitability we demonstrated in the first half of 2026.”

Zoran Milosevic, Chief Executive Officer of Meridian Holdings
4:31 PM ET 10-Q
Financial Results Maxcyte, Inc. MXCT

Maxcyte Q3 2026 Results: Net Loss of $4.76M, Loss Narrows

MaxCyte reported revenue of $10.2 million for the third quarter of 2026, a significant increase from $6.8 million in the prior year period. The company successfully reduced its quarterly net loss to $4.8 million from $12.4 million year-over-year, driven by higher gross profits and a substantial reduction in operating expenses across R&D and sales and marketing.

Key figure
Net loss $4.76M
4:31 PM ET 10-Q
Financial Results Capstone Companies, Inc. CAPC

Capstone Companies Q3 2026 Results: Net Loss of $57K, Loss Narrows

Capstone Companies, Inc. reported zero revenue for the nine months ended September 30, 2026, as it continues to search for a new business line. The company incurred a net loss of $234,143 and faces substantial doubt about its ability to continue as a going concern due to negative working capital and maturing debt obligations.

Key figure
Net loss $57K
4:31 PM ET 10-Q
Financial Results Precipio, Inc. PRPO

Precipio Q3 2026 Results: Net Loss of $8K, Loss Narrows

Precipio, Inc. reported net sales of $21.1 million for the nine months ended September 30, 2026, a significant increase from $17.4 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $1.67 million for the first nine months of 2026, compared to a net loss of $0.89 million in 2025, primarily driven by higher operating expenses.

Key figure
Net loss $8K
4:31 PM ET 10-Q
Financial Results Acme United Corp ACU

Acme United Q3 2026 Results: Net Income $3.44M, Up 80.5% YoY

Acme United Corp reported net sales of $173.0 million for the nine months ended September 30, 2026, a 16% increase over the prior year, driven in part by the acquisition of My Medic assets. Net income for the same period rose to $9.5 million, while the company significantly increased its long-term debt to $28.1 million to fund investing activities.

Key figure
Net income $3.44M · +80.5% YoY
4:31 PM ET 10-Q
Financial Results Beyond Meat, Inc. BYND

Beyond Meat Q3 2026 Results: Net Loss of $82.8M, Loss Narrows

Beyond Meat, Inc. is undergoing a strategic repositioning to 'Beyond The Plant Protein Company,' expanding into adjacent categories like powders, bars, and beverages. The company recently completed a 1-for-30 reverse stock split and an exchange offer for its convertible senior notes to address significant debt and liquidity concerns.

Key figure
Net loss $82.8M
4:31 PM ET 10-Q
Financial Results Tofutti Brands Inc TOFB

Tofutti Brands Q3 2026 Results: Net Loss of $12K, Loss Narrows

Tofutti Brands Inc. reported a net loss of $386,000 for the thirty-nine weeks ended September 26, 2026, as net sales declined to $4.58 million from $5.53 million in the prior year period. The company issued a going concern warning, noting that existing cash and anticipated flows are insufficient to fund operations for the next twelve months.

Key figure
Net loss $12K
4:31 PM ET 8-K
Financial Results Intelligent Bio Solutions Inc. INBS

Intelligent Bio Solutions Financial Results

Intelligent Bio Solutions reported record fiscal first quarter 2027 revenue of $1.39 million, a 25% increase year-over-year, driven by higher-margin cartridge sales. The company also achieved a significant regulatory milestone by submitting its FDA 510(k) premarket notification for its fingerprinting drug screening system, targeting the U.S. market.

Term
Q1 2027

“Fiscal first quarter revenue was the highest quarterly revenue in our Company’s history. Each reader draws on a recurring supply of higher-margin cartridges, which is driving most of our revenue growth. Our business continues to scale with improving unit economics, including expanding gross profit margins driven by manufacturing efficiencies and a higher share of revenue from higher-margin cartridge consumables.”

Harry Simeonidis, President and CEO

“In September, we submitted our 510(k) premarket notification to the FDA for the Intelligent Fingerprinting Drug Screening System, the culmination of the clinical program we executed throughout 2026 and a key step toward our planned entry into the multi-billion-dollar U.S. drug screening market. Going forward, we will continue to invest in the clinical and regulatory work behind our 510(k) submission while maintaining discipline across the rest of the business.”

Harry Simeonidis, President and CEO
4:31 PM ET 8-K
Financial Results Energy Vault Holdings, Inc. NRGV

Energy Vault Holdings Financial Results

Energy Vault reported Q3 2026 revenue of $13.1 million and a significant increase in contract backlog to $2.3 billion, up 147% year-over-year. The company affirmed its full-year 2026 revenue guidance of $290-$310 million and provided preliminary 2027 revenue guidance of $600-$700 million as it transitions toward a Build, Own & Operate strategy.

Term
Q3 2026

“During the third quarter, we continued advancing our integrated Build, Own & Operate strategy, expanding our global development pipeline and strengthening our cash and overall financial position. Our backlog reached $2.3 billion as of November 10th, third quarter total cash increased almost 3x year-over-year, and we achieved important financing, acquisition and development milestones that support the long-term growth of our owned infrastructure platform.”

Robert Piconi, Chairman and Chief Executive Officer
4:31 PM ET 10-Q
Financial Results Seer, Inc. SEER

Seer Q3 2026 Results: Net Loss of $13.7M, Loss Narrows

For the nine months ended September 30, 2026, Seer, Inc. reported total revenue of $9.9 million, a decrease from $12.4 million in the prior year period. The company reduced its net loss to $47.5 million compared to $57.6 million in 2025, primarily driven by a significant reduction in research and development and SG&A operating expenses.

Key figure
Net loss $13.7M
4:31 PM ET 10-Q
Financial Results Strategic Storage Trust VI, Inc. SGST

Strategic Storage Trust VI Q3 2026 Results: Net Loss of $7.4M, Loss Narrows

Strategic Storage Trust VI, Inc. reported a net loss of approximately $25.5 million for the nine months ended September 30, 2026, compared to a loss of $18.5 million in the prior year period. Total revenues increased slightly to $23.9 million, but the company faced higher operating expenses and significant foreign currency adjustments that impacted the bottom line.

Key figure
Net loss $7.4M
4:29 PM ET 8-K
Financial Results Amprius Technologies, Inc. AMPX

Amprius Technologies Financial Results

Amprius Technologies reported record Q3 2026 revenue of $39.1 million, an 83% year-over-year increase driven by strong demand in drone, aviation, and defense markets. The company improved its GAAP net loss to $3.5 million and raised its full-year 2026 revenue outlook to $145 million.

Term
Q3 2026

“Our third quarter results demonstrate the strength of our company’s technology leadership and our ability to convert growing customer demand into meaningful financial performance. We delivered record revenue, as we continued to deepen our relationships with customers across the drone, aviation, defense, and advanced mobility markets.”

Tom Stepien, CEO
4:29 PM ET 8-K
Financial Results Quicklogic Corp QUIK

Quicklogic Financial Results

QuickLogic reported fiscal third quarter 2026 revenue of $5.1 million, a 153% increase year-over-year, driven by strong growth in new product revenue. The company reported a GAAP net loss of $2.2 million ($0.12 per share) and highlighted a recent six-figure eFPGA design win in the automotive industrial sector.

Term
Q3 2026

“Our recent automotive and industrial design win is a strong validation of our eFPGA technology. Combined with our latest eFPGA Hard IP advancements and continued progress on the U.S. strategic radiation-hardened FPGA program, we are building momentum across key areas of our business and anticipate a strong finish to the year.”

Brian Faith, CEO of QuickLogic
4:28 PM ET 8-K
Financial Results Inhibikase Therapeutics, Inc. IKT

Inhibikase Therapeutics Financial Results

Inhibikase Therapeutics reported financial results for the third quarter of 2026, highlighting the expansion of its Phase 3 IMPROVE-PAH study for IKT-001 with 28 country regulatory approvals and 79 clinical sites activated. The company noted it is well-capitalized following a $50 million equity sale to RA Capital in July 2026, which will support the advancement of its PAH clinical program.

Term
Q3 2026

“During our third quarter and in recent weeks we continued to advance our Phase 3 IMPROVE-PAH study, for which we have obtained 28 country regulatory approvals in the U.S. and E.U., with 79 clinical sites activated across a range of countries.”

Mark Iwicki, Chief Executive Officer of Inhibikase

“Supported by the $50 million proceeds from the sale of shares to RA Capital in July, Inhibikase is well-positioned to advance IKT-001 toward its potential as the first once-daily oral anti-proliferative offering significant potential benefits to the PAH patient population.”

Mark Iwicki, Chief Executive Officer of Inhibikase
4:28 PM ET 10-Q
Financial Results Finwise Bancorp FINW

Finwise Bancorp Q3 2026 Results: Net Income $10M, Up 105.4% YoY

FinWise Bancorp reported total assets of $83.8 million in interest-bearing deposits as of September 30, 2026, a decrease from $151.3 million at year-end 2025. The company is focusing on its Banking-as-a-Service (BaaS) expansion and the integration of its recent acquisition of Tallied Technologies, Inc. to optimize its technology platform.

Key figure
Net income $10M · +105.4% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.